\
&
Contact us
Published on | 11 months ago
ProgrammesThe opening of the Postdoctoral Fellowships call 2025 will be postponed by one month, from 9 April to 8 May 2025. The closing date remains the same. As with previous calls the MSCA PF 2025 call will be eventually included on the European Commission Funding and Tenders portal.
To minimise the impact of the shortened application period, all information documents such as the Guide for Applicants, (static) application form, etc. will be uploaded in advance so that applicants are fully aware of all the call conditions.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.